DOI: 10.1055/s-00000054


Issue 07 · Volume 43 · November 2010 DOI: 10.1055/s-002-21447

Original Paper

Schennach-Wolff, R.; Möller, H.-J.; Jäger, M.; Seemüller, F.; Obermeier, M.; Messer, T.; Laux, G.; Pfeiffer, H.; Naber, D.; Schmidt, L. G.; Gaebel, W.; Klosterkötter, J.; Heuser, I.; Maier, W.; Lemke, M. R.; Rüther, E.; Klingberg, S.; Gastpar, M.; Riedel, M.: A Critical Analysis and Discussion of the Appropriateness of the Schizophrenia Consensus Remission Criteria in Clinical Pharmaceutical Trials
Andreasson, K.; Liest, V.; Lunde, M.; Martiny, K.; Unden, M.; Dissing, S.; Bech, P.: Identifying Patients with Therapy-Resistant Depression by using Factor Analysis
Rubio, G.; López-Muñoz, F.; Ponce, G.; Pascual, J. M.; Martínez-Gras, I.; Ferre, F.; Jiménez-Arriero, M. Á.; Alamo, C.: Zonisamide versus Diazepam in the Treatment of Alcohol Withdrawal Syndrome
González-Pinto, A.; Reed, C.; Novick, D.; Bertsch, J.; Haro, J. M.: Assessment of Medication Adherence in a Cohort of Patients with Bipolar Disorder
Bech, P.; Boyer, P.; Germain, J.-M.; Padmanabhan, K.; Haudiquet, V.; Pitrosky, B.; Tourian, K. A.: HAM-D17 and HAM-D6 Sensitivity to Change in Relation to Desvenlafaxine Dose and Baseline Depression Severity in Major Depressive Disorder


Dresler, M.; Kluge, M.; Genzel, L.; Schüssler, P.; Steiger, A.: Nocturnal Administration of Ghrelin does not Promote Memory Consolidation
Nimwegen-Campailla, L. van; Beveren, N. van; Laan, W.; Brink, W. van den; Linszen, D.; Haan, L. de: Effect of Early Dysphoric Response and Cannabis Use on Discontinuation of Olanzapine or Risperidone in Patients With Early Psychosis
Liang, C.-S.; Liao, W.-C.; Yang, F.-W.; Ho, P.-S.: Risperidone-Induced Sialorrhea: Dose-Related?
Bach, D. R.: Author's Reply D. R. Bach et al.: Elevated Bilirubin in Acute and Transient Psychotic Disorder. Pharmacopsychiatry 2010; 43: 12–16